Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1

Published:2013-06-12 Issue:12 Volume:84 Page:1407-1409
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Keung Benison,Robeson Kimberly R,DiCapua Daniel B,Rosen Jennifer B,O'Connor Kevin C,Goldstein Jonathan M,Nowak Richard J

Publisher

BMJ

Subject

Psychiatry and Mental health,Clinical Neurology,Surgery

Reference9 articles.

1. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis;Wolfe;Ann NY Acad Sci,2008

2. Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients;Illa;J Neuroimmunol,2008

3. Long-lasting treatment effect of rituximab in MuSK myasthenia;Díaz-Manera;Neurology,2012

4. Response of patients with refractory myasthenia gravis to rituximab: a retrospective study;Nowak;Ther Adv Neurol Disord,2011

5. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome;Maddison;J Neurol Neurosurg Psychiatry,2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis;Neurology Neuroimmunology & Neuroinflammation;2024-11

2. A case of refractory myasthenia gravis in the elderly demonstrating remission following rituximab therapy;Journal of Geriatric Neurology;2024-06-15

3. Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis;CNS Neuroscience & Therapeutics;2024-06

4. Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study;Therapeutic Advances in Neurological Disorders;2024-01

5. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3